Shallow fungal disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 6-75 years of age male and female; 2. meet the clinical diagnostic criteria for superficial fungal disease; 3. Skin area less than 40 % of BSA; 4. Voluntary participation in the experiment and signature of the informed consent; 5. Within one month from the date of signing the informed consent form until the last delivery, the subjects or their partners agreed to take the contraceptive measures approved by the researchers.
Exclusion criteria
Exclusion criteria: 1. A ringworm; 2. Stimulating more serious bacterial infections with fever, red poison, cellulitis; 3. Patients with other apparent skin conditions(such as contact dermatitis or suppurative infection) that may affect the evaluation of the efficacy; 4. Allergies to known components of the drug tested, or to an allergic constitution; 5. ALT, AST > 1.5 times normal range upper limit; Cr > 1.5 normal value range upper limit; 6. Drugs(such as glucocorticoids, immunosuppressants, antifungal, bacterial and antihistamines) that are required to be applied in whole or in part during the two weeks preceding the selection or during the trial; 7. Pregnancy and lactation; 8. Persons who have participated or are participating in other clinical trials within three months; 9. Other cases judged unsuitable for participation in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target Skin Damage;Effect of itching;Qualitative detection of fungi; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital signs;Medical examination;Blood routine;Urinary routine;Liver function;Renal function;12-channel electrocardiogram;Pregnancy test;Observation of adverse events(severity, incidence); | — |
Countries
China
Contacts
Second Affiliated Hospital, Hunan University of Traditional Chinese Medicine